- Home
- TNGX vs CRUS Comparison
TNGX vs CRUS Comparison
Compare TNGX & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | CRUS |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 5.9B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | TNGX | CRUS |
|---|---|---|
| Price | $8.81 | $119.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $12.50 | ★ $140.00 |
| AVG Volume (30 Days) | ★ 2.7M | 460.4K |
| Earning Date | 11-04-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.23 |
| EPS | N/A | ★ 7.02 |
| Revenue | $66,501,000.00 | ★ $1,948,426,000.00 |
| Revenue This Year | $53.01 | $0.95 |
| Revenue Next Year | N/A | $1.88 |
| P/E Ratio | ★ N/A | $17.24 |
| Revenue Growth | ★ 53.29 | 2.19 |
| 52 Week Low | $1.03 | $75.83 |
| 52 Week High | $11.20 | $136.92 |
Technical Indicators
Market Signals| Indicator | TNGX | CRUS |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 45.05 |
| Support Level | $8.89 | $121.94 |
| Resistance Level | $10.08 | $126.97 |
| Average True Range (ATR) | 0.62 | 3.03 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 8.57 | 23.46 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.